Loading clinical trials...
Loading clinical trials...
Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors Carcinoid Heart Disease (CHD): An Observational French Multi-Centre Cohort Study CRUSOE - NETs (CaRdiac UltraSonic OutcomEs - NETs)
Carcinoid Heart Disease (CHD) is a rare form of heart disease, occurring in over 50% of the patients with carcinoid syndrome. Pathophysiology, prognostic factors of development of Carcinoid Heart Disease and progression of disease remain unclear. This observational multicenter cohort study is designed to study the occurrence of Carcinoid Heart Disease in patients with differentiated carcinoid tumors, to describe numerous factors influencing the occurrence, severity, progression and long-term survival of patients with Carcinoid Heart Disease. Basic informations and detailed diagnosis informations (oncological and cardiac parameters), are collected by professional doctors. Clinical outcomes (onset of Carcinoid Heart Disease, cardiac surgery, related death) will be followed up every year or every six/three months if clinically indicated.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU Amiens
Amiens, France
CHU Angers
Angers, France
CHU Bordeaux - Hopital Haut-Lévèque
Bordeaux, France
APHP Beaujon
Clichy, France
CHU Dijon
Dijon, France
GHICL Lille
Lille, France
Centre Oscar Lambret
Lille, France
CHRU Lille
Lille, France
Hôpital Edouard HERRIOT, Institut du Cancer - Hospices Civils de Lyon
Lyon, France
Institut Paoli-Calmettes
Marseille, France
Start Date
April 16, 2018
Primary Completion Date
April 16, 2033
Completion Date
April 16, 2033
Last Updated
December 3, 2024
670
ACTUAL participants
Study of the occurrence of Carcinoid Heart Disease
OTHER
Lead Sponsor
Hospices Civils de Lyon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions